AstraZeneca Plc – Strategy, SWOT and Corporate Finance Report
- Pages: 88
- Published: March 2019
- Report Code: MLPH3904FSA
AstraZeneca Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas including respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.
Scope
Detailed information on AstraZeneca Plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting AstraZeneca Plc in the form of a SWOT analysis
An in-depth view of the business model of AstraZeneca Plc including a breakdown and examination of key business segments
News about AstraZeneca Plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of AstraZeneca Plc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess AstraZeneca Plc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on AstraZeneca Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Takeda Pharmaceutical Co Ltd
Shire Plc
Sanofi
Pfizer Inc
Novo Nordisk AS
Novartis AG
Merck & Co Inc
Johnson & Johnson
GlaxoSmithKline Plc
Gilead Sciences Inc
F. Hoffmann-La Roche Ltd
Daiichi Sankyo Co Ltd
Bristol-Myers Squibb Co
Astellas Pharma Inc
Amgen Inc
AbbVie Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.